PRMA’s Chadwick Highlights Common Omissions in Global Value Dossiers
PRMA Consulting HTA Manager Claire Chadwick in a recent blog post discusses five common omissions in global value dossiers. Chadwick [...]
Value & Outcomes Spotlight Editor-in-Chief Bids Farewell in Latest Issue
Value & Outcomes Spotlight Editor-in-Chief David Thompson bid readers farewell in the latest issue, describing his 12-plus years in the [...]
Report: Responses to Remdesivir Price Mostly Negative
Even though the Institute for Clinical for Economic Review (ICER) announced its support of remdesivir's pricing, the response has been [...]
Gilead CEO: Remdesivir Priced ‘Significantly’ Below Value to Society
Gilead CEO Daniel O'Day told STAT he's confident in the company's pricing decision for the COVID-19 drug remdesivir. "We spent [...]
Healthcare Reimbursement Market to Reach $20 billion by 2025, Report Suggests
The U.S. healthcare reimbursement market could be valued at $20 billion by 2025, according to a new report by Brand [...]
Report: FDA Mandates 50% Efficacy for COVID-19 Vaccines
Vaccine candidates must be at least 50 percent more effective than a placebo to be considered for Food and Drug [...]
Pandemic Puts Pressure on FDA on RWD
The COVID-19 pandemic has put increased pressure on the Food and Drug Administration's real-world data initiatives. According to a Pink [...]
Mental Care Utilization Poised to be Key Driver of Health Spending Next Year
PwC in a new analysis suggests utilization of mental care services will be a key driver of health spending next [...]
Report on PBM Market Forecasts 7% CAGR Between 2019-2025
A new report from Arizton forecasts a compound annual growth rate of 7 percent for the pharmacy benefit management market [...]
Webinar to Highlight Marketplace Trends, COVID-19’s Impact
The Academy of Managed Care Pharmacy (AMCP) is set to host a July 9 webinar on trends in the health [...]
Reminder: ICER Accepting Comments on Annual Unsupported Price Increase Assessment
The Institute for Clinical and Economic Review (ICER) is accepting public input on the target drugs for this year's Unsupported [...]
PhRMA Foundation Extends Deadline on Applications for Value Assessment Awards
The PhRMA Foundation announced an extended application deadline for the foundation's 2020 Value Assessment Awards. Applications are due July 15. [...]
Gilead Sets Price for Remdesivir
Gilead announced it would charge between $2,340 and $3,120 for a 5-day course of its COVID-19 drug remdesivir, BioPharma Dive [...]
ICER President: Remdesivir Price was ‘Responsible’ Decisions
The Institute for Clinical and Economic Review's president, Steven Pearson, says Gilead's decision to price its COVID-19 treatment remdesivir at [...]
DistillerSR Week 2020 Recap Reel
The Evidence Partners posted a quick highlight reel of DistillerSR Week 2020, its first-ever virtual user conference. Click here to [...]
PRMA’s Nathan White: Why Understanding Payer Archetypes is Key to U.S. Market Access
Via PRMA Consulting Until recently, pharma’s biggest market access challenge in the U.S. has been learning to navigate "known unknowns." [...]
Oncologists Grapple with Supply Shortages Amid Pandemic, Survey Finds
A new survey found that one of oncologists' biggest concerns amid the COVID-19 pandemic is supply shortages, Specialty Pharmacy Continuum [...]
Pricing a COVID-19 Vaccine
A recent episode of NPR's INDICATOR offers a look at the issue of pricing a vaccine for COVID-19. The episode [...]
How is COVID-19 Impacting RWD-Based Initiatives in Oncology?
A recent OncLive article looks at how the COVID-19 pandemic is shaping real-world data initiatives in the oncology landscape. The [...]
Proposed Medicaid Changes Aim to Foster Innovative Contracts
The Centers for Medicare and Medicaid Services (CMS) is hoping to encourage greater use of innovative contracting models in a [...]
Cytel Outlines Use of Bayesian Methodologies
A new white paper from Cytel outlines how its statisticians have used Bayesian methodologies in the search for effective COVID-19 [...]
IQVIA Offering On-Demand Webinar on RWE
IQVIA is offering on-demand access to its recent web event on real-world evidence. The webinar was hosted in partnership with [...]
CSRxP’s Aronson: Pharma Must Halt Summer Price Hikes
The Campaign for Sustainable Rx Pricing (CSRxP) is calling on the pharmaceutical industry to halt summer price hikes as the [...]
Article Highlights Causes, Potential Solutions for High Drug Prices
While there are "no easy solutions" to high drug prices, there are a number of steps that could help wrangle [...]
ISPOR Plans Educational Webinar for Members
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar aimed at helping members bolster [...]